What's New in Breast Cancer - Susan G. Komen®
Learn about new breast cancer treatment breakthroughs and recent developments in research that are fueling new ways to assess risk, prevent, detect and diagnose breast cancer.
Estrogen a more powerful breast cancer culprit than we ...
May 17, 2023 · A Harvard Medical School study shows the sex hormone estrogen — thus far thought to be only a fuel for breast cancer growth — can directly cause tumor-driving genomic rearrangements.
New study finds triple-negative breast cancer tumors with an ...
Apr 25, 2024 · A new multicenter, international study suggests that people who have early-stage triple-negative breast cancer (TNBC) and high levels of immune cells within their tumors may have a lower risk of recurrence and better survival rates even when not …
Breast cancer deaths in the US continue to fall, but new ...
Oct 1, 2024 · The study, published Tuesday in CA: A Cancer Journal for Clinicians, found some good news: The overall breast cancer death rate in the US dropped about 44% between 1989 and 2022, which...
Breast cancer treatment: Drug Kisqali approval expanded for ...
Sep 17, 2024 · The FDA expanded the approval of Kisqali, a drug for metastatic breast cancer, to treat patients with earlier stage cancer, Novartis said. The drug was found to reduce the risk of a patient's...
Targeted therapy shows benefit for people with advanced ... - CNN
Dec 8, 2022 · CNN — An experimental treatment shows promise for people with the most common form of advanced-stage breast cancer, according to results from a Phase 3 clinical trial. The details of the trial...
Experimental immunotherapy targets metastatic breast cancer
Feb 1, 2022 · Many people with metastatic breast cancer can mount an immune reaction against their tumors, the study found, a prerequisite for this type of immunotherapy, which relies on what are called tumor-infiltrating lymphocytes (TILs).
Breast Cancer Drug Trial Results in ‘Unheard-Of’ Survival
Jun 7, 2022 · The clinical trial, sponsored by the pharmaceutical companies Daiichi Sankyo and AstraZeneca and led by Dr. Shanu Modi of Memorial Sloan Kettering Cancer Center, involved 557 patients with...
Breast cancer - Latest research and news | Nature
Oct 30, 2024 · Breast cancer articles from across Nature Portfolio. Breast cancer is caused by the development of malignant cells in the breast. The malignant cells originate in the lining of the milk...
Enhertu Effective in HER2-Positive Metastatic Breast Cancer
Oct 19, 2021 · In people with metastatic HER2-positive breast cancer, the targeted drug trastuzumab deruxtecan (Enhertu) markedly lengthened progression-free survival compared with trastuzumab emtansine (Kadcycla), new study results show.